TEVA

#364
Teva Pharmaceutical Industries Limited American Depositary Shar
34.6 7 USD
+0.38%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
34.55
34.95
Year Range
0.34
37.34
Daily Change
+0.38%
Monthly Change
-3.51%
6 month change
+30.39%
Year Change
+81.47%
Previous Close
34.5 4
Open
34.8 0
Low
34.5 5
High
34.9 5
Volume
655
Open full chart Full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 40.37 B
  • Employee 33 K
  • Founded N/A
  • CEO Richard Francis
  • Website www.tevapharm.com
  • Headquarter Israel
  • FIGI BBG000C0CD58
  • Industry Drug Manufacturers—Specialty & Generic
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
22.48
Price to sales ratio
2.49

Teva Pharmaceutical Industries Limited American Depositary Shar

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients and, to a lesser extent, contract manufacturing services and an out-licensing platform. Teva's primary branded products include Austedo which is used for the treatment of chorea associated with Huntington's disease and tardive dyskinesia; and Ajovy, used for the preventive treatment of migraine in adults. Additional branded drugs sold by Teva include Copaxone, Bendeka and Treanda, all of which are primarily sold in the United States. Teva is listed on the Tel Aviv Stock Exchange and the New York Stock Exchange. Its manufacturing facilities are located in Israel, North America, Europe, Australia, and South America. The company is a member of the Pharmaceutical Research and Manufacturers of America. Teva Pharmaceuticals is the largest generic drug manufacturer in the world. Overall, Teva is the 26th largest pharmaceutical company in the world. Teva has a history of legal trouble in relation to collusion and price-fixing to inflate prices for drugs.

News